600568 ST中珠医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-1.389-29.511-13.097-24.995-5.715
总资产报酬率 ROA (%)-1.150-24.136-10.218-19.564-4.704
投入资产回报率 ROIC (%)-1.326-28.162-11.963-22.363-5.345

边际利润分析
销售毛利率 (%)18.58712.76425.22525.19128.609
营业利润率 (%)-7.381-120.568-52.841-153.849-31.671
息税前利润/营业总收入 (%)-6.908-121.203-55.768-160.161-32.917
净利润/营业总收入 (%)-7.483-119.906-52.996-156.488-35.884

收益指标分析
经营活动净收益/利润总额(%)139.92123.12830.46822.93930.690
价值变动净收益/利润总额(%)0.00027.3501.6570.7151.751
营业外收支净额/利润总额(%)-15.992-0.2120.2882.8591.824

偿债能力分析
流动比率 (X)3.7953.6894.5223.9704.727
速动比率 (X)3.0622.7753.0592.6083.133
资产负债率 (%)17.16017.81914.18920.89916.358
带息债务/全部投入资本 (%)2.3002.3142.3212.2041.090
股东权益/带息债务 (%)4,158.4004,118.9764,115.1333,991.5288,317.946
股东权益/负债合计 (%)484.152462.933572.895360.577493.316
利息保障倍数 (X)12.684136.27120.09989.79150.104

营运能力分析
应收账款周转天数 (天)50.91161.14252.36361.07258.546
存货周转天数 (天)196.991336.762443.498605.314564.397